Status:
COMPLETED
EndoClot for Hemostasis and Preventing Post-procedure Bleeding After Endoscopic Mucosal Resection
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Conditions:
Endoscopic Hemostasis
Colonic Polyps
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Endoscopic mucosal resection (EMR) has been widely used as a diagnostic and treatment techniques of gastrointestinal small lesions. Para-procedure bleeding is one of the common complication following ...
Eligibility Criteria
Inclusion
- consecutive cases of colorectal polyps and submucosal tumors with anticipated complete removal endoscopically by EMR.
Exclusion
- severe cardiovascular diseases, liver and kidney dysfunction;
- platelet and coagulation dysfunction (PLT \< 50\*109/L, INR \> 2);
- cases that have taken anticoagulant drugs or non-steroidal anti-inflammatory drugs within 1 month before the procedure;
- cases unavailable for follow-up.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT01496781
Start Date
April 1 2010
End Date
March 1 2012
Last Update
April 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, China, 710032